These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 25179081
1. The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet. Wierucka-Rybak M, Wolak M, Bojanowska E. J Physiol Pharmacol; 2014 Aug; 65(4):487-96. PubMed ID: 25179081 [Abstract] [Full Text] [Related]
2. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat. Bojanowska E, Radziszewska E. J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840 [Abstract] [Full Text] [Related]
3. Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice. Mathes CM, Ferrara M, Rowland NE. Pharmacol Biochem Behav; 2009 Nov; 94(1):119-23. PubMed ID: 19660493 [Abstract] [Full Text] [Related]
4. Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1 receptor activity affects feeding behavior and body weight in rats fed a free-choice, high-carbohydrate diet. Radziszewska E, Wolak M, Bojanowska E. Behav Pharmacol; 2014 Feb; 25(1):53-60. PubMed ID: 24370558 [Abstract] [Full Text] [Related]
5. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats. Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M. Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644 [Abstract] [Full Text] [Related]
6. Characterization of a shortened model of diet alternation in female rats: effects of the CB1 receptor antagonist rimonabant on food intake and anxiety-like behavior. Blasio A, Rice KC, Sabino V, Cottone P. Behav Pharmacol; 2014 Oct; 25(7):609-17. PubMed ID: 25011007 [Abstract] [Full Text] [Related]
7. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P. Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190 [Abstract] [Full Text] [Related]
13. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats. Rivera P, Luque-Rojas MJ, Pastor A, Blanco E, Pavón FJ, Serrano A, Crespillo A, Vida M, Grondona JM, Cifuentes M, Bermúdez-Silva FJ, de la Torre R, de Fonseca FR, Suárez J. Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907 [Abstract] [Full Text] [Related]
14. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys. Wagner JD, Zhang L, Kavanagh K, Ward GM, Chin JE, Hadcock JR, Auerbach BJ, Harwood HJ. J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903 [Abstract] [Full Text] [Related]